Molecular Targeting and Rational Chemotherapy in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a molecularly complex disease with multiple aberrant genetic pathways involved in its pathogenesis. Approximately one-third to one-half of patients with AML would relapse, and no standard therapy is established for relapsing and/or refractory AML (RR-AML) yet. It is u...

Descripción completa

Detalles Bibliográficos
Autores principales: Pourrajab, Fatemeh, Zare-Khormizi, Mohamad Reza, Hekmatimoghaddam, Seyedhossein, Hashemi, Azam Sadat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269636/
https://www.ncbi.nlm.nih.gov/pubmed/32581600
http://dx.doi.org/10.2147/JEP.S254334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269636/
https://www.ncbi.nlm.nih.gov/pubmed/32581600
http://dx.doi.org/10.2147/JEP.S254334

Ejemplares similares